These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [The use of Cosaldon retard in ophthalmological practice (author's transl)]. Hasslinger C Klin Monbl Augenheilkd; 1973 Dec; 163(6):755-60. PubMed ID: 4788875 [No Abstract] [Full Text] [Related]
5. [Cosaldon in the treatment of senile macular degeneration]. Gerkowicz K Klin Oczna; 1973 Aug; 43(8):893-7. PubMed ID: 4742598 [No Abstract] [Full Text] [Related]
6. [Experimental investigations on drug induced improvement of brain metabolism]. Köhler W Wien Klin Wochenschr; 1972 May; 84(21):340-3. PubMed ID: 5064086 [No Abstract] [Full Text] [Related]
7. [Experiences with new Cosaldon forms]. Dammann C Med Klin; 1969 Feb; 64(8):344-8. PubMed ID: 5783023 [No Abstract] [Full Text] [Related]
8. [Long-term treatment of senile macular degeneration with Cosaldon A+E]. Stark H Klin Monbl Augenheilkd; 1985 Oct; 187(4):296-302. PubMed ID: 3934458 [TBL] [Abstract][Full Text] [Related]
9. [Treatment of cardiac and cerebrovascular insufficiency with Card-Cosaldon. Result of a field study]. Koeppen G; Schmidt-Modrow G Ther Ggw; 1979 Nov; 118(11):1704-13. PubMed ID: 538738 [No Abstract] [Full Text] [Related]
10. [On the treatment of arteriosclerotic retinopathy with Cosaldon A+E (author's transl)]. Zielinski HW Klin Monbl Augenheilkd; 1978 Dec; 173(6):857-64. PubMed ID: 732204 [TBL] [Abstract][Full Text] [Related]
11. Cosaldon for vascular disorders? Drug Ther Bull; 1972 Aug; 10(17):66-8. PubMed ID: 4570865 [No Abstract] [Full Text] [Related]
12. [Effect of cosaldon A + E in presbycusis. Tone and speech audiometric studies]. Bachmann W Med Welt; 1980 Aug; 31(35):1255-8. PubMed ID: 7421561 [No Abstract] [Full Text] [Related]
13. [Experience with Cosaldon retard in double blind studies]. Dreyer H; Keussen M; Wojtek L Dtsch Med J; 1969 May; 20(10):356-8. PubMed ID: 4919479 [No Abstract] [Full Text] [Related]
14. [Cosaldon retard in the treatment of optic neuritis and macular degeneration]. Myszka A Klin Oczna; 1979; 81(2):161-2. PubMed ID: 439725 [No Abstract] [Full Text] [Related]
15. [On the circulation promoting treatment in parkinsonism]. Völler G Hippokrates; 1969 May; 40(10):393-7. PubMed ID: 5803728 [No Abstract] [Full Text] [Related]
16. The value of cosaldon in cerebral arteriosclerosis. FELSTEIN IL Br J Clin Pract; 1963 Aug; 17():448-9. PubMed ID: 13962885 [No Abstract] [Full Text] [Related]
17. [On the treatment of cerebral and peripheral vascular disorders in general practice]. Glashoff E Ther Ggw; 1969 Jan; 108(1):88-95. PubMed ID: 5763821 [No Abstract] [Full Text] [Related]
18. [Treatment of cerebral arteriosclerosis with cosaldon]. SPERLING R Med Klin; 1960 May; 55():845-7. PubMed ID: 13833290 [No Abstract] [Full Text] [Related]
19. A REPORT ON THE USE OF COSALDON IN GENERAL PRACTICE. WALDRON DH Br J Clin Pract; 1963 Dec; 17():733-4. PubMed ID: 14084642 [No Abstract] [Full Text] [Related]
20. [Control of cerebral blood circulation time during long-term Wallerox therapy. Measurements using external scintillation counters]. Herzfeld U; Erbe H Med Welt; 1971 Nov; 48(71):1933-5. PubMed ID: 5002422 [No Abstract] [Full Text] [Related] [Next] [New Search]